Pila Pharma Overview
- Year Founded
-
2014
- Status
-
Public
- Employees
-
3
- Stock Symbol
-
PILA
- Investments
-
2
- Share Price
-
$0.17
- (As of Friday Closing)
Pila Pharma General Information
Description
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.
Contact Information
Website
www.pilapharma.comCorporate Office
- Norra Vallgatan 72
- 211 22 Malmo
- Sweden
Corporate Office
- Norra Vallgatan 72
- 211 22 Malmo
- Sweden
Pila Pharma Stock Performance
As of 13-Nov-2026, Pila Pharma’s stock price is $0.17. Its current market cap is $7.6M with 45.7M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.17 | $0.17 | $0.10 - $0.28 | $7.6M | 45.7M | 81.2K | -$0.06 |
Pila Pharma Financials Summary
As of 30-Jun-2026, Pila Pharma has a trailing 12-month revenue of $29.5K.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 4,335 | 6,702 | 9,011 | 3,845 |
| Revenue | 29 | 115 | 73 | 138 |
| EBITDA | (1,694) | (1,621) | (961) | (829) |
| Net Income | (1,776) | (1,731) | (1,063) | (934) |
| Total Assets | 1,735 | 1,762 | 564 | 846 |
| Total Debt | 0 | 0 | 0 | 0 |
Pila Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Pila Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Pila Pharma Comparisons
Industry
Financing
Details
Pila Pharma Competitors (12)
One of Pila Pharma’s 12 competitors is Vicore Pharma Holding, a Formerly VC-backed company based in Stockholm, Sweden.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vicore Pharma Holding | Formerly VC-backed | Stockholm, Sweden | ||||
| TRPV Pharmaceuticals | Corporation | Stuart, FL | ||||
| Coherus Oncology | Formerly VC-backed | Redwood City, CA | ||||
| AbbVie | Corporation | North Chicago, IL | ||||
| AlzeCure Pharma | Corporate Backed or Acquired | Huddinge, Sweden |
Pila Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Pila Pharma Patents
Pila Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2003229734-A1 | Hydroxy tetrahydro-naphthalenylurea derivatives | Active | 08-May-2002 | ||
| AU-2003229734-B2 | Hydroxy tetrahydro-naphthalenylurea derivatives | Inactive | 08-May-2002 | ||
| CA-2487238-A1 | Hydroxy tetrahydro-naphthalenylurea derivatives | Active | 08-May-2002 | ||
| CA-2487238-C | Hydroxy tetrahydro-naphthalenylurea derivatives | Inactive | 08-May-2002 | ||
| US-20060258742-A1 | Such as n-[4-chloro-3-(trifluoromethyl)phenyl]-n'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, copd | Active | 08-May-2002 | C07C275/42 |
Pila Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pila Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Pila Pharma Investments (2)
Pila Pharma’s most recent deal was a Later Stage VC with Dilafor for . The deal was made on 27-Sep-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Dilafor | 27-Sep-2016 | Later Stage VC | Drug Discovery | ||
| Ario Pharma (TRPV1 Antagonist Molecule) | 30-Mar-2016 | Corporate Asset Purchase | Buildings and Property |
Pila Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Pila Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Pila Pharma Danmark | Koebenhavn Oe, Denmark | 2017 |
Pila Pharma FAQs
-
When was Pila Pharma founded?
Pila Pharma was founded in 2014.
-
Where is Pila Pharma headquartered?
Pila Pharma is headquartered in Malmo, Sweden.
-
What is the size of Pila Pharma?
Pila Pharma has 3 total employees.
-
What industry is Pila Pharma in?
Pila Pharma’s primary industry is Drug Discovery.
-
Is Pila Pharma a private or public company?
Pila Pharma is a Public company.
-
What is Pila Pharma’s stock symbol?
The ticker symbol for Pila Pharma is PILA.
-
What is the current stock price of Pila Pharma?
As of 13-Nov-2026 the stock price of Pila Pharma is $0.17.
-
What is the current market cap of Pila Pharma?
The current market capitalization of Pila Pharma is $7.6M.
-
What is Pila Pharma’s current revenue?
The trailing twelve month revenue for Pila Pharma is $29.5K.
-
Who are Pila Pharma’s competitors?
Vicore Pharma Holding, TRPV Pharmaceuticals, Coherus Oncology, AbbVie, and AlzeCure Pharma are some of the 12 competitors of Pila Pharma.
-
What is Pila Pharma’s annual earnings per share (EPS)?
Pila Pharma’s EPS for 12 months was -$0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
